Nuzenio

Ind Approval

Ind Approval news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Ind-Swift Laboratories secures 99.99% shareholder approval for ₹137.20 crore warrant issue - scanx.tradescanx.trade · Fri, 07 Aug 2026 12:59:09 GMT Leads Biolabs Wins IND Approval to Test Opamtistomig in Metastatic Colorectal Cancer - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMT FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy - Ophthalmology Times EuropeOphthalmology Times Europe · Mon, 03 Aug 2026 19:02:58 GMT IND open for Ractigen’s RAG-1C in proliferative vitreoretinopathy - bioworld.combioworld.com · Mon, 03 Aug 2026 13:00:00 GMT Harbour BioMed and Kelun-Biotech receive China IND approval for bispecific asthma therapy - BioSpectrum AsiaBioSpectrum Asia · Mon, 03 Aug 2026 10:41:15 GMT InSilico Medicine Cayman TopCo Receives NMPA IND Approval for ISM8969/HT-001, Blood-Brain-Barrier-Penetrant NLRP3 Inhibitor Co-Developed with Hygtia Therapeutics Co., Ltd - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 05:21:39 GMT Nanjing Leads Biolabs Says Lbl-024 Receives IND Approval From NMPA For Metastatic Colorectal Cancer - TradingViewTradingView · Mon, 03 Aug 2026 01:44:00 GMT FDA Clears Ractigen IND Application for Novel saRNA Candidate in Proliferative Vitreoretinopathy - Contract PharmaContract Pharma · Fri, 31 Jul 2026 14:54:44 GMT

Timeline

Fri, 07 Aug 2026 12:59:09 GMTInd-Swift Laboratories secures 99.99% shareholder approval for ₹137.20 crore warrant issue - scanx.trade

Wed, 05 Aug 2026 19:39:16 GMTLeads Biolabs Wins IND Approval to Test Opamtistomig in Metastatic Colorectal Cancer - BioPharm International

Mon, 03 Aug 2026 19:02:58 GMTFDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy - Ophthalmology Times Europe

Mon, 03 Aug 2026 13:00:00 GMTIND open for Ractigen’s RAG-1C in proliferative vitreoretinopathy - bioworld.com

Mon, 03 Aug 2026 10:41:15 GMTHarbour BioMed and Kelun-Biotech receive China IND approval for bispecific asthma therapy - BioSpectrum Asia

Mon, 03 Aug 2026 05:21:39 GMTInSilico Medicine Cayman TopCo Receives NMPA IND Approval for ISM8969/HT-001, Blood-Brain-Barrier-Penetrant NLRP3 Inhibitor Co-Developed with Hygtia Therapeutics Co., Ltd - marketscreener.com

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Metastatic Colorectal Cancer4 live mentions RAG4 live mentions Ophthalmology Times Europe3 live mentions The Manila Times3 live mentions Ind2 live mentions Swift Laboratories2 live mentions Test Opamtistomig2 live mentions FDA Clears IND2 live mentions IND2 live mentions Ractigen2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ind Approval.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.